Literature DB >> 31376068

Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.

Sandeep Kumar Singh1, Saurabh Srivastav2, Rudolph J Castellani3, Germán Plascencia-Villa4, George Perry5.   

Abstract

Alzheimer's disease (AD) is the most common progressive human neurodegenerative disorder affecting elderly population worldwide. Hence, prevention of AD has been a priority of AD research worldwide. Based on understanding of disease mechanism, different therapeutic strategies involving synthetic and herbal approaches are being used against AD. Among the herbal extract, Ginkgo biloba extract (GBE) is one of the most investigated herbal remedy for cognitive disorders and Alzheimer's disease (AD). Standardized extract of Ginkgo biloba is a popular dietary supplement taken by the elderly population to improve memory and age-related loss of cognitive function. Nevertheless, its efficacy in the prevention and treatment of dementia remains controversial. Specifically, the added effects of GBE in subjects already receiving "conventional" anti-dementia treatments have been to date very scarcely investigated. This review summarizes recent advancements in our understanding of the potential use of Ginkgo biloba extract in the prevention of AD including its antioxidant property. A better understanding of the mechanisms of action of GBE against AD will be important for designing therapeutic strategies, for basic understanding of the underlying neurodegenerative processes, and for a better understanding of the effectiveness and complexity of this herbal medicine.

Entities:  

Keywords:  Alzheimer’s disease; Antioxidant; Dietary supplement; Ginkgo biloba extract; Herbal compounds; Neurodegenerative disease

Mesh:

Substances:

Year:  2019        PMID: 31376068      PMCID: PMC6694352          DOI: 10.1007/s13311-019-00767-8

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  111 in total

1.  Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761).

Authors:  Reham Abdel-Kader; Susanne Hauptmann; Uta Keil; Isabel Scherping; Kristina Leuner; Anne Eckert; Walter E Müller
Journal:  Pharmacol Res       Date:  2007-09-15       Impact factor: 7.658

2.  Supplementation of the Pure Flavonoids Epicatechin and Quercetin Affects Some Biomarkers of Endothelial Dysfunction and Inflammation in (Pre)Hypertensive Adults: A Randomized Double-Blind, Placebo-Controlled, Crossover Trial.

Authors:  James I Dower; Johanna M Geleijnse; Lieke Gijsbers; Casper Schalkwijk; Daan Kromhout; Peter C Hollman
Journal:  J Nutr       Date:  2015-05-13       Impact factor: 4.798

3.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons.

Authors:  M Simons; P Keller; B De Strooper; K Beyreuther; C G Dotti; K Simons
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 4.  Alzheimer´s disease and oxidative stress: a review.

Authors:  Miroslav Pohanka
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 5.  Alzheimer's disease, the nematode Caenorhabditis elegans, and ginkgo biloba leaf extract.

Authors:  Yuan Luo
Journal:  Life Sci       Date:  2006-02-28       Impact factor: 5.037

6.  Neuron degeneration induced by verapamil and attenuated by EGb761.

Authors:  L Zhu; J Gao; Y Wang; X N Zhao; Z X Zhang
Journal:  J Basic Clin Physiol Pharmacol       Date:  1997

7.  Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease.

Authors:  Yuan Luo
Journal:  J Alzheimers Dis       Date:  2001-08       Impact factor: 4.472

8.  Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  R J Ferrante; A M Klein; A Dedeoglu; M F Beal
Journal:  J Mol Neurosci       Date:  2001-08       Impact factor: 2.866

9.  Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation.

Authors:  Mingjin Jiang; Jing Li; Qiuxian Peng; Yi Liu; Wei Liu; Chaohua Luo; Ju Peng; Junkui Li; Ken Kin Lam Yung; Zhixian Mo
Journal:  J Neuroinflammation       Date:  2014-09-26       Impact factor: 8.322

10.  Complementary and alternative medicine use among US Navy and Marine Corps personnel.

Authors:  Tyler C Smith; Margaret A K Ryan; Besa Smith; Robert J Reed; James R Riddle; Gia R Gumbs; Gregory C Gray
Journal:  BMC Complement Altern Med       Date:  2007-05-16       Impact factor: 3.659

View more
  40 in total

1.  Neurotherapeutics of the Aging Brain: Complexity Meets Complexity.

Authors:  Alan J Lerner; Andrew A Pieper
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

2.  Rejuvenation increases leaf biomass and flavonoid accumulation in Ginkgo biloba.

Authors:  Zhaogeng Lu; Likui Zhu; Jinkai Lu; Nan Shen; Lu Wang; Sian Liu; Qingjie Wang; Wanwen Yu; Hisashi Kato-Noguchi; Weixing Li; Biao Jin; Li Wang; Jinxing Lin
Journal:  Hortic Res       Date:  2022-01-18       Impact factor: 6.793

3.  Ginkgo biloba extracts inhibit post-ischemic LTP through attenuating EPSCs in rat hippocampus.

Authors:  Yong Liu; Supeng Ding; Yifei Luan; Zhichao Zhu; Yuting Cai; Yingkui Liu
Journal:  Metab Brain Dis       Date:  2021-08-31       Impact factor: 3.584

4.  In vivo protective effects of Ginkgo biloba L. leaf extract against hydrogen peroxide toxicity: cytogenetic and biochemical evaluation.

Authors:  Emine Yalçın; Kültiğin Çavuşoğlu; Ali Acar; Kürşad Yapar
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-14       Impact factor: 4.223

5.  Molecular cloning and expression analysis of a WRKY transcription factor gene, GbWRKY20, from Ginkgo biloba.

Authors:  Tingting Zhou; Xiaoming Yang; Guibin Wang; Fuliang Cao
Journal:  Plant Signal Behav       Date:  2021-05-23

6.  The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation.

Authors:  Jia Ke; Meng-Ting Li; Ya-Jing Huo; Yan-Qiong Cheng; Shu-Fen Guo; Yang Wu; Lei Zhang; Jianpeng Ma; Ai-Jun Liu; Yan Han
Journal:  Drug Des Devel Ther       Date:  2021-08-14       Impact factor: 4.162

7.  Go-sha-jinki-Gan Alleviates Inflammation in Neurological Disorders via p38-TNF Signaling in the Central Nervous System.

Authors:  Shiying Jiang; Kousuke Baba; Keisuke Hagihara; Hideki Mochizuki; Tatsusada Okuno; Makoto Kinoshita; Chi-Jing Choong; Hideki Hayakawa; Hiroshi Sakiyama; Kensuke Ikenaka; Seiichi Nagano; Tsutomu Sasaki; Munehisa Shimamura; Yoshitaka Nagai
Journal:  Neurotherapeutics       Date:  2020-10-20       Impact factor: 7.620

Review 8.  Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis.

Authors:  Germán Plascencia-Villa; George Perry
Journal:  Antioxid Redox Signal       Date:  2020-07-17       Impact factor: 8.401

9.  Hypoxia-induced apoptosis of cardiomyocytes is restricted by ginkgolide B-downregulated microRNA-29.

Authors:  Dezhi Ren; Fang Li; An Gao; Qingwen Cao; Yarong Liu; Junru Zhang
Journal:  Cell Cycle       Date:  2020-04-16       Impact factor: 4.534

Review 10.  Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimer's Disease and Its Neuropsychiatric Symptoms.

Authors:  Catia Scassellati; Antonio Carlo Galoforo; Ciro Esposito; Miriam Ciani; Giovanni Ricevuti; Cristian Bonvicini
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.